In terms of the non-insured health benefits, it is a program that has rising costs every year. Typically that's because we're always adding new drugs, for example, so there would be an expanded range of drugs. But it's not a major policy expansion. It's simply that as new drugs come on the market and they are assessed, they are added to the formulary, for example.
In addition, we have increased population. We are covering more people because this is a growing population, so that leads to increased costs as well.
Where we have been able to have some new programming in recent years--and we are able to continue that with the $285 million in this coming budget--is in the area of youth suicide prevention and maternal and child health. These are programs that have been started in more recent years, and this money will allow us to continue those, to refine them, and to make sure that in addition to the very important treatment services we have some services on the prevention side as well.